Third quarter 2026 earnings call, October 29, 2026

AXT reported third quarter revenue of $73.4 million, up 54% sequentially and 162% from $28.0 million a year earlier, and guided the fourth quarter to roughly $90 million of revenue it has either already permitted or does not need permits to ship. The more important disclosure was that backlog has moved above $500 million, from a figure management had only described as "more than $100 million" a quarter ago. Non-GAAP EPS of $0.41 compares with $0.19 in the second quarter and a $0.03 loss a year ago, and fourth quarter non-GAAP EPS guidance of $0.57 to $0.59 implies another step up of roughly 40%.

Backlog Quintuples, but Not Because of Long-Term Agreements

The backlog figure includes long-term multiyear agreements, contracts of 12 months or less and spot purchase orders running through 2027. Northland's Tim Savageaux pressed on how much of the $300 million to $400 million sequential increase came from long-term supply agreements. VP of Business Development Tim Bettles was direct: it is "run rate business," and long-term agreements are "a relatively small part" of the total. The Lumentum agreement, which carried a $43.5 million wafer prepayment recorded as a liability, is the one signed in the third quarter and not a follow-on.

CFO Gary Fischer said this is deliberate. Management has pulled back on formal long-term agreements because it wants to protect price and avoid being locked into volume commitments. "We're not going to be announcing multiple long-term agreements," he said, even though "plenty of customers want us to sign up for them." For investors, this cuts both ways. The backlog is shorter-dated and more reliant on spot and annual pricing than a contract-heavy book would be, which leaves AXT exposed if the market turns, but it also lets the company capture further price increases in a supply-constrained market. Bettles said lead times have stretched beyond nine months, all customers are on allocation, and customers with existing long-term agreements are asking to raise volumes two to three times.

Gross Margin Resets Above 56%, With More Guided

Non-GAAP gross margin reached 56.1%, from 45.0% in the second quarter and 22.4% a year ago. Savageaux calculated incremental gross margin of 77% in the quarter. Management attributed the gain to volume, a richer indium phosphide mix, higher market prices, the shift from 3-inch to 4-inch wafers and manufacturing efficiency gains from higher volume. Fischer said he did not think margins had peaked and that the fourth quarter could start with a 6, "not a high 6." He added that "it's pretty obvious that we're going to cross over 60%" but declined to give a longer-term target given how fast conditions are changing.

The drivers beyond near-term mix are worth understanding. A new generation of proprietary crystal growth furnaces, originally purchased for 6-inch development, is also delivering large productivity gains on 4-inch laser material. CEO Morris Young pointed to demand for tighter etch pit density, or EPD, specifications on high-power lasers as another pricing lever, noting that "low EPD is our forte" and that tighter requirements mean "less competition and that's a premium to the price." Young said that when AXT first qualified with a major U.S. laser maker the requirement was below 500, and the company now delivers less than one-tenth of that. Raw material costs are rising significantly, but Young said efficiency, productivity and low-EPD gains "overwhelm" the cost increase. Early 6-inch yields are expected to be low, which is a modest headwind until more furnaces come online.

Capacity: Tripling in 2026, Doubling Again in 2027, and Still Short

AXT said it surpassed its goal of doubling indium phosphide capacity in August. Fischer indicated that, indexed to end-2025 at 1.0, capacity should reach about 2.75 to 3.0 by the end of 2026, with a goal of doubling again in 2027. A newly acquired adjacent building is in the design phase for conversion to indium phosphide production, with work starting within months. Young said the company's indium phosphide revenue opportunity has "more than quadrupled" in 2026 relative to where it began the year. Bettles said potential revenue capacity is "a lot higher" than the figures management offered last quarter, which an analyst recalled as roughly $60 million and $130 million for successive periods, helped by larger wafers and higher average selling prices. He said essentially all of the incremental fourth quarter revenue will be indium phosphide, implying quarterly indium phosphide revenue of well over $54.3 million.

Asked by Needham's Charles Shi about investor concern that AXT is building toward overcapacity in 2027, management rejected the premise. Bettles said that in 2027 "I'm not sure we'll even get our head above water," and Fischer said the CFO's view is that 2027 and 2028 capital spending is "less than is going to be needed." Young said a major customer told him the addressable market could expand "1,000x" and not 20x across scale-up, scale-out and scale-across architectures, though he admitted he did not know how that figure was derived. He was more cautious beyond the near term, saying he is confident for the next two years and that "three years out, it's hard to say." Fischer said capex would be reassessed as 2029 approaches. Investors should note that the argument rests on management's read of customer forecasts and allocation, and that new Chinese entrants are pursuing indium phosphide substrates, though Young argued 40 years of crystal growth experience cannot be quickly replicated.

Wafer Diameter Transition Is the 2027 Pricing Story

Bettles laid out the shift in diameters. In 2026, lasers are largely on 3-inch and photodetectors are on 4-inch. In 2027, laser material begins moving to 4-inch, and by the end of the year the company could see equal 3-inch and 4-inch wafer volumes. Young said 3-inch was the fastest-growing segment in 2026, with 4-inch expected to take that role next year. Six-inch remains in the single digits as a share of 2027 revenue but should command strong margins as it ramps. Management said only two companies are currently at the front of 6-inch indium phosphide, AXT and one other that Young said is now "probably equal to us," with the third a "very distant third." The 6-inch lines are moving into pilot production. Many competitors remain stuck predominantly on 3-inch, according to Bettles.

China Demand Strengthens

Young said indium phosphide revenue into the China laser market "increased strongly at the end" of the third quarter and that all China customers are on allocation. Management stressed that shipments within China do not require export licenses, which makes this demand easier to fulfill than export-restricted business. Fischer's fourth quarter revenue visibility of about $90 million is explicitly limited to revenue with permits in hand or not needed, so permitting remains a gating factor for any upside beyond that. In the U.S., management believes its material is deployed across multiple hyperscalers, with demand from EML and silicon photonics transceivers, high-speed detectors and emerging continuous-wave lasers for scale-up.

Tongmei Financing and Hong Kong Listing

AXT disclosed that Tongmei, its majority-owned subsidiary, signed a definitive agreement for a private equity financing, selling its own shares and not AXT shares. Assuming the maximum investment of USD 545 million, AXT would retain control with approximately 73.4% ownership, a reduction of about 12.1 percentage points. Proceeds will fund indium phosphide wafer capacity and expansion at the raw material companies in China. The financing precedes Tongmei's planned Hong Kong Stock Exchange listing. The trade-off for AXT shareholders is a lower economic interest in the operating subsidiary in exchange for non-dilutive growth capital, and this comes on top of a balance sheet that already holds $825.9 million in cash and investments, up $77 million in the quarter. DSO improved to 49 days on multiple customer prepayments, and inventory rose $7.4 million.

Raw Materials and Gallium Arsenide

Subsidiary Jin Mei is now refining high-purity indium, giving AXT direct control over a critical input, and AXT is investing to expand its capacity. Raw material company revenue was $9.7 million. Indium phosphide revenue was $54.3 million, gallium arsenide was $9.1 million and germanium was $344,000. Gallium arsenide demand grew sequentially across wireless, industrial robotics and data center lasers, although management expects several end markets to be seasonally down in the fourth quarter. Young highlighted customers showcasing slow and wide VCSEL lasers for data centers on 6-inch and 8-inch gallium arsenide, a potential longer-term opening where AXT leads in substrate diameter.

Operating Costs and Guidance

Non-GAAP operating expense rose to $11.7 million from $10.2 million in the second quarter and is guided to roughly $13 million in the fourth quarter, or about $14 million on a GAAP basis. Non-GAAP operating margin was 40.2%. Share count is expected at about 66.1 million. Top five customers were about 35% of revenue, with one above 10%. Fischer noted that fourth quarter gross margin improvement depends on revenue mix, fixed cost absorption and manufacturing efficiency. Young summarized the situation with unusual candor: "We always believed that indium phosphide will represent a big opportunity for AXT, but I can honestly say we didn't expect it to be so big."